Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001

Emerging Infectious Diseases

Volumn 8, Issue 10, 2002, Pages 1133-1137

  Williams, Jennifer L ^a   Noviello, Stephanie S ^a   Griffith, Kevin S ^b   Wurtzel, Heather ^a   Hamborsky, Jennifer ^a   Perz, Joseph F ^a   Williams, Ian T ^a   Hadler, James L ^a   Swerdlow, David L ^a   Ridzon, Renee ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CDC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; DOXYCYCLINE; INFLUENZA VACCINE;

ABDOMINAL PAIN; ABSENTEEISM; ADULT; AGED; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; DIARRHEA; DRUG INDUCED DISEASE; EMPLOYEE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OCCUPATIONAL EXPOSURE; PATIENT COMPLIANCE; POSTAL MAIL; PRURITUS; QUESTIONNAIRE; UNITED STATES; VOMITING;

EID: 0036775266     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0810.020346     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related inhalational anthrax - Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1049-51.
2. Barkat LA, Quentzel HL, Jernigan JA, Kirchke DL, Griffith K, Spear SM, et al. Fatal inhalational anthrax in a 94-year old Connecticut woman. JAMA 2002;287:863-8.
3. Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax - Connecticut, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1077-9.
4. Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees - New Jersey, New York City, and the District of Columbia metropolitan area, 2001. MMWR Morb Mortal Wkly Rep 2001;50:1051-4.
5. Friedlander AM, Welkos SL, Pitt MLM, Ezzell JW, Warsham PL, Rose KJ, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis 1993;167:1239-42.
6. Cieslak TJ, Eitzen EM. Clinical and epidemiologic principles of anthrax. Emerg Infect Dis 1999;5:552-5.
7. Centers for Disease Control and Prevention. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb Mortal Wkly Rep 2001;50;889-93.
8. Centers for Disease Control and Prevention. Notice to readers: Interim guidelines for investigation of and response to Bacillus anthracis exposures. MMWR Morb Mortal Wkly Rep 2001;50;987-90.
9. Teshale EH, Painter J, Burr GA, Mead P, Wright SV, Cseh LF, et al. Environmental sampling for spores of Bacillus anthracis. Emerg Infect Dis 2002;8;1083-7.
10. Code of Federal Regulations 21CFR 600.80. Updated 2001.
11. Shepard C, the National Anthrax Bioterrorism Response Team. Adverse events associated with postexposure antimicrobial prophylaxis for prevention of anthrax - Florida, New Jersey, New York City, Maryland, Virginia, and Washington, D.C., 2001. Poster session presented at the Annual Meeting of the Epidemic Intelligence Service, Atlanta, GA, 2002.